Skip to main content
. 2016 Jan;36(1):114–131. doi: 10.1038/jcbfm.2015.147

Table 5.

Follow-up status for patients after 2 years.

Follow-up status Total, n % SCI at baseline, n % MCI at baseline, n %
Conversion to dementia
 AD 21 7 0 0 21 12
 MixD 12 4 0 0 12 7
 SVD 10 3 2 2 8 5
 Dementia, other 5 2 0 0 5 3
Nonconverting
 Stable MCI 68 23 0 0 68 38
 Stable SCI 69 24 69 61 0 0
 SCI–MCI 21 7 21 19 0 0
 MCI–SCI 38 13 0 0 38 21
 MCI–healthy 3 1 0 0 3 2
No follow-up data
 Round skipped 3 1 2 2 1 1
 Deceased 1 <1 0 0 1 1
 Somatic disease 2 1 1 1 1 1
 Examination declined 35 12 16 14 19 11
 No information 4 1 2 2 2 1
Total, n 292 113 179

AD, Alzheimer’s disease; MCI, mild cognitive impairment; MixD, mixed type dementia (=AD + SVD); SCI, subjective cognitive impairment; SVD, subcortical vascular dementia. AD = conversion from Global deterioration scale (GDS) 2 or 3 to GDS 4 + fulfillment of AD criteria. SVD = conversion from GDS 2 or 3 to GDS 4 + fulfillment of SVD criteria. MixD = conversion from GDS 2 or 3 to GDS 4 + fulfillment of MixD criteria. Dementia, other = conversion from GDS 2 or 3 to GDS 4 (after 2 years 4 nonultra descriptum (NUD) and 1 primary progressive aphasia (PPA), after 6 years 3 additional NUD. Stable MCI = first and current examination GDS 3. Stable SCI = first and current examination GDS 2. SCI–MCI = first examination GDS 2 and current examination GDS 3. MCI–SCI = first examination GDS 3 and current examination GDS 2. MCI–healthy = first examination GDS 3 and current examination GDS 1. Round skipped = current round skipped, next examination carried out. Missing follow-up: deceased. Somatic disease = not followed up due to somatic disease. Examination declined = further examination declined. No information = not followed up, no information available.